Sandra Dehning

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

Norbert Müller, Markus Schwarz, Sandra Dehning et al. · Molecular Psychiatry · 2006 · 795 citations

Medicine, Pharmacology, Psychiatry +17

Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment

Norbert Müller, Daniela Krause, Sandra Dehning et al. · Schizophrenia Research · 2010 · 255 citations

Medicine, Pharmacology, Pharmacotherapy +9

European clinical guidelines for Tourette syndrome and other tic disorders. Part IV: deep brain stimulation

Kirsten Müller‐Vahl, Daniëlle C. Cath, Andrea E. Cavanna et al. · European Child & Adolescent Psychiatry · 2011 · 157 citations · Full text

Medicine, Neurology, Psychiatry +17

Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression — No influence of celecoxib treatment

Richard Musil, Markus Schwarz, Michael Riedel et al. · Journal of Affective Disorders · 2011 · 126 citations

Medicine, Pharmacology, Psychiatry +17

Public Stigma against People with Mental Illness in the Gilgel Gibe Field Research Center (GGFRC) in Southwest Ethiopia

Eshetu Girma, Markos Tesfaye, Guenter Froeschl et al. · PLoS ONE · 2013 · 125 citations · Full text

Medicine, Community Health, Psychiatry +17